Aditxt Subsidiary Ignite to Spin Off via $150M SPAC Merger; New Investor Discloses Stake
ADTX has more than doubled off its 52-week low of $0.004 on elevated volume (13× avg).
Summary
Aditxt's subsidiary, Ignite Proteomics, is set to spin off through a SPAC merger with Copley Acquisition Corp, valuing the combined entity at $150 million. This transaction, which includes up to $30 million in financing and aims for a NYSE listing, is expected to close by September 30. This follows an 8-K filed on June 10th that announced the SPAC merger, with this news providing specific terms and confirming the valuation. Separately, Takeover Time 2026 LLC has disclosed an investment stake in Aditxt. The $150 million valuation for Ignite is highly material given Aditxt's extremely low market capitalization and ongoing financial distress, including a Nasdaq delisting notice. This deal could provide a significant capital infusion and unlock substantial value for the company.
At the time of this announcement, ADTX was trading at $0.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7K. The 52-week trading range was $0.00 to $53,450.61. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.